RxDoctor Payments Data

Brett Faulknier, DO

Clinical Cardiac Electrophysiology · Vero Beach, FLNPI 1346380771

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,156 of the $13,724 with a category attached, or 74.0%. 14 manufacturers reported payments, led by Abbott at 49.8% of the total. Reporting peaked in 2022 at $5,225 and has fallen 62.0% since, to $1,986 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.

$13,724in general payments, 2019–2025

Across 277 payments — averaging $49.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$7K
  • Medtronic$4K
  • Boston Scientific$2K
  • Atricure, Inc.$495
  • Impulse Dynamics (USA) Inc.$176
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$156
  • plus $237 from 8 others
$1,430in research payments, 2019–2025

Across 4 payments — averaging $357.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$1K

What the payments were for

  • Travel & lodging$3,37925%
  • Food & beverage$10,15674%
  • Education$1901%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,724 in reported general payments places this provider in the 30th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024
$315,270
Medicare patients
651
Services billed
2,398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$35,715
Dofetilide20$5,224
Flecainide Acetate14$570
SotalolSotalol Hcl13$374
Cephalexin42$164
Metoprolol Succinate21$156

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Vero Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →